Eculizumab use in catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis from the “CAPS Registry”

B López-Benjume, I Rodríguez-Pintó, MC Amigo… - Autoimmunity …, 2022 - Elsevier
Objectives To describe the real-world experience of eculizumab use in patients with
catastrophic antiphospholipid syndrome (CAPS) according to the information provided by …
被引用次数：52 相关文章

Eculizumab use in catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis from the" CAPS Registry".

B López-Benjume, I Rodríguez-Pintó… - Autoimmunity …, 2022 - europepmc.org
Objectives To describe the real-world experience of eculizumab use in patients with
catastrophic antiphospholipid syndrome (CAPS) according to the information provided by …

Eculizumab use in catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis from the" CAPS Registry"

B López-Benjume, I Rodríguez-Pintó… - Autoimmunity …, 2022 - pubmed.ncbi.nlm.nih.gov
Objectives To describe the real-world experience of eculizumab use in patients with
catastrophic antiphospholipid syndrome (CAPS) according to the information provided by …